Paper950465
C3 requirements for formation of alternative pathway C5 convertase.
Daha MR and 2 others. J Immunol, 1976. Cited by 107 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. C3 requirements for formation of alternative pathway C5 convertase. Papers, record 950465. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/950465
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement C3 | Major topic |
| Complement C5 | Major topic |
| Complement System Proteins | Major topic |
| Erythrocytes | Major topic |
| Cell Membrane | |
| Esterases | |
| Hemolysis |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 107 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34,948,444 | Complement System in Alzheimer's Disease. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34948444 | PubMed |
| 34,705,082 | The emerging role of complement in neuromuscular disorders. | Semin Immunopathol | 2021 | https://conductscience.org/library/papers/34705082 | PubMed |
| 33,687,995 | Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics. | Pharmacol Rev | 2021 | https://conductscience.org/library/papers/33687995 | PubMed |
| 32,765,498 | Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma. | Front Immunol | 2020 | https://conductscience.org/library/papers/32765498 | PubMed |
| 31,871,188 | An inhibitor of complement C5 provides structural insights into activation. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/31871188 | PubMed |
| 27,018,802 | Structural basis for therapeutic inhibition of complement C5. | Nat Struct Mol Biol | 2016 | https://conductscience.org/library/papers/27018802 | PubMed |
| 26,335,102 | Complement Activation in Patients with Focal Segmental Glomerulosclerosis. | PLoS One | 2015 | https://conductscience.org/library/papers/26335102 | PubMed |
| 20,304,920 | Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20304920 | PubMed |
| 19,368,894 | The crystal structure of cobra venom factor, a cofactor for C3- and C5-convertase CVFBb. | Structure | 2009 | https://conductscience.org/library/papers/19368894 | PubMed |
| 18,594,868 | Nephritic factor and recurrence in the renal transplant of membranoproliferative glomerulonephritis type II. | Pediatr Nephrol | 2008 | https://conductscience.org/library/papers/18594868 | PubMed |
| 8,398,646 | Activated C3 (C3b) in the nephritic glomerulus. | Pediatr Nephrol | 1993 | https://conductscience.org/library/papers/8398646 | PubMed |
| 8,288,944 | Properdin: approaching four decades of research. | Immunol Res | 1993 | https://conductscience.org/library/papers/8288944 | PubMed |
| 7,259,350 | Reduction in alternative complement pathway mediated C3 conversion following burn injury. | Ann Surg | 1981 | https://conductscience.org/library/papers/7259350 | PubMed |
| 6,950,410 | Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6950410 | PubMed |
| 6,934,510 | Evidence for presence of an internal thiolester bond in third component of human complement. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6934510 | PubMed |
| 6,902,727 | Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme. | J Clin Invest | 1980 | https://conductscience.org/library/papers/6902727 | PubMed |
| 6,863,540 | Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6863540 | PubMed |
| 6,776,531 | Active site amino acid sequence of human factor D. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6776531 | PubMed |
| 6,576,376 | Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6576376 | PubMed |
| 6,447,230 | Pathopysiological aspects of immune complex diseases. Part II. Phagocytosis, exocytosis, and pathogenic depositions. | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/6447230 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 | NCBI Gene |
| C5 | 727 | PubTator's text mining | https://conductscience.org/library/genes/727 | NCBI Gene |
| ERVK-3 | 100,862,689 | PubTator's text mining | https://conductscience.org/library/genes/100862689 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/950465
GET https://conductscience.org/api/papers/v1/950465/cited_by?page=2